PositoAI/ US/ Nuvation Bio Inc.

Nuvation Bio Inc.

NYSE: NUVB · Healthcare

Positivity Index

#5,442 / 6,774

Global

#2,960 / 4,000

United States

Positivity Score

17,376

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Nuvation Bio Inc. — Overview & Financial Snapshot

Nuvation Bio Inc. (NYSE: NUVB) is a Healthcare company, ranked #5,442 of 6,774 companies globally and #2,960 of 4,000 in United States on PositoAI, with a Positivity Score of 17,376. Its market capitalisation is ₹15,577.12 Cr ($1.65B), P/E ratio is -10.7 and P/B ratio is 6.50. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.

P/B Ratio 6.50

P/E Ratio -10.7

D/E Ratio 1.64

ROE -47.81%

Owes vs Owns ? 0.66× Moderate $0.66 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-41.53$-0.44

Forward EPS ₹-1.42$-0.02

Beta 1.62

Market Cap ₹15,577.12 Cr$1.65B

What these numbers mean →

What does Nuvation Bio Inc. do?

What is Nuvation Bio Inc.'s P/E and P/B ratio?

Nuvation Bio Inc. has a P/E ratio of -10.7 and a P/B ratio of 6.50.

What is Nuvation Bio Inc.'s debt-to-equity ratio?

Nuvation Bio Inc. has a debt-to-equity ratio of 1.64.

How much does Nuvation Bio Inc. owe compared with what it owns?

Nuvation Bio Inc. owes $0.66 for every $1 it owns (balance sheet Jun 2026), which is moderate.

What is Nuvation Bio Inc.'s Positivity rank?

Nuvation Bio Inc. is ranked #5,442 of 6,774 companies globally and #2,960 of 4,000 in United States on PositoAI, with a Positivity Score of 17,376.

Does Nuvation Bio Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Nuvation Bio Inc..

Where can I read the latest news about Nuvation Bio Inc.?

Recent headlines about Nuvation Bio Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Nuvation Bio Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Nuvation Bio Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.